Vascular BioSciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
72 Santa Felicia Dr, Goleta, California,...Phone Number
(858) 273-2744Website
www.vascularbiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Vascular BioSciences
Vascular BioSciences specializes in developing innovative medical products and therapies aimed at enhancing and prolonging human life. Their offerings include CAR peptide technology for targeted treatments in pulmonary hypertension, COVID-19, and sepsis, as well as the world's first endoarterial biopsy catheter for minimally invasive vascular disease diagnosis. The company also provides molecular diagnostic solutions to analyze biopsy samples and profile vascular diseases. Their intended clients include healthcare providers and patients dealing with serious vascular-related conditions.Explore more
Vascular BioSciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vascular BioSciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Vascular BioSciences had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Vascular BioSciences has new funding data
Check if Vascular BioSciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Vascular BioSciences
Product Launch: Get notified when Vascular BioSciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Vascular BioSciences is spiking on competitors!
Earning: See what the market has to say on Vascular BioSciences recently announced quarterly report
Vascular BioSciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Vascular BioSciences
Find 3 more new buyers
Compare Similar Companies to Vascular BioSciences
Compare insights from companies similar to Vascular BioSciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vascular BioSciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vascular BioSciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vascular BioSciences.
Vascular BioSciences Tech Stack
A closer look at the technologies used by Vascular BioSciences
Vascular BioSciences News & Media
FDA Grants Vascular BioSciences Humanitarian Use Device (HUD) Designation to the Endoarterial Biopsy Catheter for Group 1 Pulmonary Arterial Hypertension
Vascular Biosciences (VBS) is pleased to announce the receipt of a Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA) for the Endoarterial Biopsy Catheter (EABC) to take pulmonary artery biopsies in patients who have Group 1 pulmonary arterial hypertension (PAH). “With cancer therapy, tissue and molecular diagnostics allow for very successful targeted therapy approaches. But [PR.com]
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vascular BioSciences
Sign Up For FreeTo access detailed company insights
Vascular BioSciences specializes in developing innovative medical products and therapies aimed at enhancing and prolonging human life. Their offerings include CAR peptide technology for targeted treatments in pulmonary hypertension, COVID-19, and sepsis, as well as the world's first endoarterial biopsy catheter for minimally invasive vascular disea... Read More
